Quote:
Originally Posted by stanleychief
Totally understand all of that, and agree. There was insufficient data to guide a lot of decisions early on. I still think vaccines are useful. However, I do have a few minor counterpoints here:
1) The vaccine I am referring to is the Janssen vaccine (Johnson and Johnson), which is not using mRNA. It's more traditional than the Pfizer and Moderna vaccines.
2) The two articles that I linked to in my original post were written on 7/8/2021 and 7/20/2021. Granted the Delta variant is newer, but I would hope for better consistency in the publication of attention grabbing headlines. Because sadly, that is about as far as most people read these days.
I think my biggest concern is the lack of interest in knowing which vaccine I had and when. It seems like that would be critical information to have in evaluating real-world effectiveness in a vaccine. Perhaps they feel they have enough data? I dunno.
|
This NYT article is about a month old, but it provides a pretty good overview of what we know about J&J's effectiveness and the likelihood of booster recommendations.
https://www.nytimes.com/2021/08/19/h...e-booster.html